Literature DB >> 15832606

Severe refractory status epilepticus owing to presumed encephalitis.

Uri Kramer1, Zamir Shorer, Bruria Ben-Zeev, Tally Lerman-Sagie, Hadassa Goldberg-Stern, Eli Lahat.   

Abstract

The severe refractory type of status epilepticus is very rare in the pediatric population. Eight children with the severe refractory type of status epilepticus owing to presumed encephalitis are described. The age at the onset of status epilepticus of the eight study children ranged between 2.5 and 15 years. Seven of the eight children presented with fever several days prior to the onset of seizures. A comprehensive clinical and laboratory investigation failed to delineate a cause for their seizures. Burst suppression coma was induced by pentothal, midazolam, propofol, or ketamine in all of the children. The mean duration of anesthesia was 28 days (range 4-62 days), but the seizures persisted in spite of repeated burst suppression cycles in all of them. Two children died. Four of the surviving children continued to suffer from seizures, and cognitive sequelae were present throughout follow-up in four children. In summary, the severe refractory type of status epilepticus of the acute symptomatic type owing to relatively mild encephalitis carries a high mortality rate and poor morbidity in terms of seizures and cognition at follow-up.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832606     DOI: 10.1177/08830738050200030301

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

1.  Ketamine for Refractory Status Epilepticus: A Systematic Review.

Authors:  Anna Rosati; Salvatore De Masi; Renzo Guerrini
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749

2.  Early ketamine to treat refractory status epilepticus.

Authors:  Andreas H Kramer
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

3.  Guidelines for the evaluation and management of status epilepticus.

Authors:  Gretchen M Brophy; Rodney Bell; Jan Claassen; Brian Alldredge; Thomas P Bleck; Tracy Glauser; Suzette M Laroche; James J Riviello; Lori Shutter; Michael R Sperling; David M Treiman; Paul M Vespa
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

4.  Treatment of status epilepticus: an international survey of experts.

Authors:  James J Riviello; Jan Claassen; Suzette M LaRoche; Michael R Sperling; Brian Alldredge; Thomas P Bleck; Tracy Glauser; Lori Shutter; David M Treiman; Paul M Vespa; Rodney Bell; Gretchen M Brophy
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 5.  [Management of refractory status epilepticus from a neurologic and neuropediatric perspective].

Authors:  B Pohlmann-Eden; U Stephani; I Krägeloh-Mann; B Schmitt; U Brandl; M Holtkamp
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

Review 6.  Invasive seizure monitoring in the critically-Ill brain injury patient: Current practices and a review of the literature.

Authors:  Charles B Mikell; Timothy G Dyster; Jan Claassen
Journal:  Seizure       Date:  2016-06-18       Impact factor: 3.184

Review 7.  NMDA antagonists for refractory seizures.

Authors:  F A Zeiler; J Teitelbaum; L M Gillman; M West
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

8.  Claustrum damage and refractory status epilepticus following febrile illness.

Authors:  Stefano Meletti; Jana Slonkova; Iva Mareckova; Giulia Monti; Nicola Specchio; Petr Hon; Giada Giovannini; Vaclav Marcian; Annalisa Chiari; Petr Krupa; Nicola Pietrafusa; Dagmar Berankova; Michal Bar
Journal:  Neurology       Date:  2015-09-04       Impact factor: 9.910

Review 9.  Status epilepticus and refractory status epilepticus management.

Authors:  Nicholas S Abend; David Bearden; Ingo Helbig; Jennifer McGuire; Sona Narula; Jessica A Panzer; Alexis Topjian; Dennis J Dlugos
Journal:  Semin Pediatr Neurol       Date:  2014-12-12       Impact factor: 3.042

10.  Risk factors associated with death in in-hospital pediatric convulsive status epilepticus.

Authors:  Tobias Loddenkemper; Tanvir U Syed; Sriram Ramgopal; Deepak Gulati; Sikawat Thanaviratananich; Sanjeev V Kothare; Amer Alshekhlee; Mohamad Z Koubeissi
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.